ArticleJournal of clinical hypertension (Greenwich, Conn.)2025
Association of Total Mortality and Cardiovascular Endpoints With the Timing of the First and Second Systolic Peak of the Aortic Pulse Wave.
Yi-Bang Cheng, De-Wei An, Lucas S Aparicio, Qi-Fang Huang, Yu-Ling Yu, Chang-Sheng Sheng, Teemu J Niiranen, Fang-Fei Wei, José Boggia, Katarzyna Stolarz-Skrzypek and 13 more
Abstract read
In one paragraphArticle in Journal of clinical hypertension (Greenwich, Conn.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
23 authors.
Yi-Bang ChengDepartment of Cardiovascular Medicine, Shanghai Key Laboratory of Hypertension, Shanghai Institute of Hypertension, State Key Laboratory of Medical Genomics, National Research Centre for Translational Medicine, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.ORCID 0000-0002-3822-3504 De-Wei AnDepartment of Cardiovascular Medicine, Shanghai Key Laboratory of Hypertension, Shanghai Institute of Hypertension, State Key Laboratory of Medical Genomics, National Research Centre for Translational Medicine, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.ORCID 0000-0002-1395-7050 Lucas S AparicioServicio de Clínica Médica, Sección Hipertensión Arterial, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
Qi-Fang HuangDepartment of Cardiovascular Medicine, Shanghai Key Laboratory of Hypertension, Shanghai Institute of Hypertension, State Key Laboratory of Medical Genomics, National Research Centre for Translational Medicine, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.ORCID 0000-0002-9780-4237 Yu-Ling YuNon-Profit Research Association Alliance for the Promotion of Preventive Medicine, Leuven, Belgium.ORCID 0000-0002-8255-3770 Chang-Sheng ShengDepartment of Cardiovascular Medicine, Shanghai Key Laboratory of Hypertension, Shanghai Institute of Hypertension, State Key Laboratory of Medical Genomics, National Research Centre for Translational Medicine, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.ORCID 0000-0003-2685-0663 Teemu J NiiranenDepartment of Chronic Disease Prevention, Finnish Institute for Health and Welfare, Turku, Finland.ORCID 0000-0002-7394-7487 Fang-Fei WeiDepartment of Cardiology, the First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, China.ORCID 0000-0002-4254-5215 José BoggiaCentro de Nefrología and Departamento de Fisiopatología, Hospital de Clínicas, Universidad de la República, Montevideo, Uruguay.ORCID 0000-0002-1564-8534 Katarzyna Stolarz-SkrzypekFirst Department of Cardiology, Interventional Electrocardiology and Hypertension, Jagiellonian University Medical College, Kraków, Poland.ORCID 0000-0002-7057-7302 Natasza Gilis-MalinowskaHypertension Unit, Department of Hypertension and Diabetology, Medical University of Gdańsk, Gdańsk, Poland.ORCID 0000-0002-6633-202X Wiktoria WojciechowskaFirst Department of Cardiology, Interventional Electrocardiology and Hypertension, Jagiellonian University Medical College, Kraków, Poland.ORCID 0000-0003-3075-3508 Krzysztof NarkiewiczHypertension Unit, Department of Hypertension and Diabetology, Medical University of Gdańsk, Gdańsk, Poland.ORCID 0000-0001-5949-5018 Kalina Kawecka-JaszczFirst Department of Cardiology, Interventional Electrocardiology and Hypertension, Jagiellonian University Medical College, Kraków, Poland.ORCID 0000-0002-8660-2867 Ji-Guang WangDepartment of Cardiovascular Medicine, Shanghai Key Laboratory of Hypertension, Shanghai Institute of Hypertension, State Key Laboratory of Medical Genomics, National Research Centre for Translational Medicine, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.ORCID 0000-0001-8511-1524 Tim S NawrotResearch Unit Environment and Health, Department of Public Health and Primary Care, University of Leuven, Leuven, Belgium.ORCID 0000-0002-3583-3593 Yan LiDepartment of Cardiovascular Medicine, Shanghai Key Laboratory of Hypertension, Shanghai Institute of Hypertension, State Key Laboratory of Medical Genomics, National Research Centre for Translational Medicine, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.ORCID 0000-0002-5825-5968 Jan A StaessenDepartment of Cardiovascular Medicine, Shanghai Key Laboratory of Hypertension, Shanghai Institute of Hypertension, State Key Laboratory of Medical Genomics, National Research Centre for Translational Medicine, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.ORCID 0000-0002-3026-1637 International Database of Central Arterial Properties for Risk Stratification (IDCARS) Investigators
Funding
Belgium (Leuven): European Union HEALTH-F7-305507 HOMAGECharles University Research FundCzech Republic: European Union HEALTH-F4-2007-201550Czech Republic: European Union LSHM-CT-2006-037093European Research Area Net for Cardiovascular Diseases JTC2017-046-PROACTEuropean Research Council 2011-294713-EPLOREEuropean Research Council 713601-uPROPHETFinnish Foundation for Cardiovascular ResearchFinnish Research CouncilFoundation for Polish ScienceItaly: European Union HEALTH-F4-2007201550Italy: European Union LSHM-CT-2006037093National Key Research and Development Projects 2022YFC3602400National Key Research and Development Projects 2022YFC3602401National Natural Science Foundation of China 81970353National Natural Science Foundation of China 82070432National Natural Science Foundation of China 82070435National Natural Science Foundation of China 82270469Poland (Gdańsk): European Union HEALTH-F4-2007201550Poland (Gdańsk): European Union LSHM-CT-2006037093Poland (Kraków): European Union HEALTH-F4-2007201550Poland (Kraków): European Union LSHM-CT-2006037093Shanghai Commissions of Science and Technology 19ZR144330Shanghai Commissions of Science and Technology 21TS1400300Shanghai Municipal Health Commission 201940297Shanghai Municipal Health Commission 2022LJ022Shanghai Municipal Health Commission 202340035Shanghai Municipal Health Commission 20234Y0036Shanghai Municipal Health Commission GWV-10.1-XK05Shanghai Shenkang Hospital Development Center SHDC2020CR1042BThe Internal Medicine Service, Hospital Italiano de Buenos Aires, Buenos Aires
6 · The paper itselfAbstract
Prognostic significance of the timing in the cardiac cycle of the first (TP1) and second (TP2) systolic peak of the central aortic pulse wave is ill-defined. Incidence rates and standardized multivariable-adjusted hazard ratios (HRs) of adverse health outcomes associated with TP1 and TP2, estimated by the SphygmoCor software, were assessed in the International Database of Central Arterial Properties for Risk Stratification (IDCARS) (n = 5529). Model refinement was assessed by the integrated discrimination (ID) and net reclassification (NR) improvement. Over 4.1 years (median), 201 participants died and 248 and 159 patients experienced cardiovascular or cardiac endpoints. Mean TP1 and TP2, standardized for cohort, sex, age, and heart rate, were 103 and 228 ms. Shorter TP1 and TP2 were associated with higher mortality and shorter TP1 with a higher risk of cardiovascular and cardiac endpoints (trend p ≤ 0.004). The HRs relating total mortality and cardiovascular endpoints to TP2 were 0.82 (95% confidence interval [CI]: 0.72-0.94) and 0.87 (0.77-0.98), respectively. The HR relating cardiac endpoints to TP1 was 0.81 (0.68-0.97). For total mortality and cardiovascular endpoints in relation to TP2, NRI was significant (p ≤ 0.010), but not for cardiac endpoints in relation to TP1. Integrated discrimination improvement (IDI) was not significant for any endpoint. The HRs relating total mortality to TP2 were smaller (p ≤ 0.026) in women than men (0.67 vs. 0.95) and in older (≥ 60 years) versus younger (< 60 years) participants (0.80 vs. 0.88). Our study adds to the evidence supporting risk stratification based on aortic pulse analysis by showing that TP2 and TP1 carry prognostic information.
Indexed as
AortaCardiovascular DiseasesPulse Wave AnalysisAgedFemaleHeart RateHumansIncidenceMaleMiddle AgedPrognosisRisk AssessmentRisk FactorsSystoleTime Factorscardiovascular riskmortalitypopulation sciencepulse wave transit timewaveform analysis
Identifiers
PMID39821625
PMCPMC11771774
What Socratic holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390